- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03495856
4-week Mindfulness Program for Adults With Chronic Pain
July 30, 2019 updated by: University of North Carolina, Chapel Hill
Feasibility of a 4-week, Adapted Mindfulness Program for Adults With Chronic Pain
The objective of this study is to determine the feasibility and acceptability of a 4-week mindfulness training program for adults with chronic pain (noncancer related).
The intervention is based on the MIndfulness-based Stress Reduction Program, an 8-week mindfulness training program developed to help people manage stress-related and chronic conditions.
The adapted mindfulness intervention will consist of four, weekly 1 hour and 30 minute group sessions that are modified from the original program to fit the shorter length and to directly address chronic pain management.
Participants will complete pre- and post-intervention surveys and daily mindfulness practice diaries, all online.
The surveys will help us determine if participants experience decreased pain interference, increased quality-of-life, and increased psychological well-being over the course of the intervention.
Participants will also complete a post-intervention telephone interview to help determine satisfaction with the intervention and areas where the intervention can be improved.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
23
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
North Carolina
-
Chapel Hill, North Carolina, United States, 27599
- University of North Carolina at Chapel Hill
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- One or more chronic noncancer pain diagnoses (daily pain for at least 3 months)
- Has a pain management provider
- Reports more than minimal pain bothersomeness and interference in general activities
- Able to read and understand English
Exclusion Criteria:
- Diagnosis of mental illness with psychotic features
- History of inpatient admission for psychiatric disorder in past 2 years
- Active alcohol or substance abuse within the past year
- Has completed a mindfulness-based stress reduction or other mindfulness course; has or previously had a regular mindfulness meditation practice.
- Unable or unwilling to comply with study procedures (online questionnaires and practice diaries, 4 weekly intervention sessions, home practice, and one semi-structured phone interview).
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: NA
- Interventional Model: SINGLE_GROUP
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: Mindfulness Training For Chronic Pain
The intervention is adapted from the mindfulness-based stress reduction program.
The adapted mindfulness training program consists of four, weekly 90 minute group sessions that focus on education on chronic pain and mindfulness, instruction and in-class mindfulness skills practice, and group discussion.
|
4-week group Mindfulness training program for adults with chronic pain
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Feasibility - Study Retention
Time Frame: 4 weeks
|
Proportion of participants enrolled who completed the study
|
4 weeks
|
|
Feasibility - Session Attendance
Time Frame: 4 weeks (intervention weeks 1-4)
|
Average sessions attended (proportion)
|
4 weeks (intervention weeks 1-4)
|
|
Credibility and Expectancy Questionnaire Scores
Time Frame: Intervention week 2
|
Credibility and Expectancy Questionnaire.
Each item is scored separately and rated on a scale from 1 [not at all] to 10 [very].
Scores for each item range from 1-10, with higher ratings indicating higher credibility and expectancy.
|
Intervention week 2
|
|
Acceptability - Intervention Satisfaction
Time Frame: 4 weeks (within one week post-intervention)
|
Question assessing participants satisfaction with the intervention
|
4 weeks (within one week post-intervention)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Pain Intensity Scores
Time Frame: Baseline and 4 weeks (pre to post-intervention)
|
Pain intensity rating: 1 item from the Patient Reported Outcomes Measurement Information System (PROMIS), with pain intensity rated on 0-10 scale with lower values indicating less pain, or better outcome.
|
Baseline and 4 weeks (pre to post-intervention)
|
|
Pain Interference Scores
Time Frame: Baseline and 4 weeks (pre to post-intervention)
|
Pain Interference short-form 6b, Patient Reported Outcomes Measurement Information System scale.
Raw scores were converted using the HealthMeasures scoring service to standardized T-Scores with M=50, SD=10 and ranging from 20 to 80.
A lower score indicates lower pain interference, or a better outcome.
|
Baseline and 4 weeks (pre to post-intervention)
|
|
Physical Functioning Scores
Time Frame: Baseline and 4 weeks (pre to post-intervention)
|
Physical functioning short-form 4a - Patient Reported Outcomes Measurement Information System scale.
Raw scores were converted using the HealthMeasures scoring service to standardized T-Scores with M=50, SD=10 and ranging from 20 to 80.
A higher score indicates higher physical functioning, or a better outcome.
|
Baseline and 4 weeks (pre to post-intervention)
|
|
Depression Short-Form 4a Scores
Time Frame: Baseline and 4 weeks (pre to post-intervention)
|
Depression short-form 4a - Patient Reported Outcomes Measurement Information System scale.
Raw scores were converted using the HealthMeasures scoring service to standardized T-Scores with M=50, SD=10 and ranging from 20 to 80.
A lower score indicates less depression, a better outcome.
|
Baseline and 4 weeks (pre to post-intervention)
|
|
Anxiety Short-Form 4a Scores
Time Frame: Baseline and 4 weeks (pre to post-intervention)
|
Anxiety short-form 4a - Patient Reported Outcomes Measurement Information System.
Raw scores were converted using the HealthMeasures scoring service to standardized T-Scores with M=50, SD=10 and ranging from 20 to 80. Lower scores represent lower anxiety, a better outcome.
|
Baseline and 4 weeks (pre to post-intervention)
|
|
Sleep Disturbance Short-Form 4a Scores
Time Frame: Baseline and 4 weeks (pre to post-intervention)
|
Sleep disturbance short-form 4a - Patient Reported Outcomes Measurement Information System.
Raw scores were converted using the HealthMeasures scoring service to standardized T-Scores with M=50, SD=10 and ranging from 20 to 80. Lower scores represent less sleep disturbance, a better outcome.
|
Baseline and 4 weeks (pre to post-intervention)
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Perceived Stress Scale Scores
Time Frame: Baseline and 4 weeks (pre to post-intervention)
|
Perceived Stress Scale - 4 item version.
Possible scores range from 0-16.
Lower scores indicate lower perceived stress, a better outcome.
|
Baseline and 4 weeks (pre to post-intervention)
|
|
Positive Affect and Well-being Scores
Time Frame: Baseline and 4 weeks (pre to post-intervention)
|
Positive Affect and Well-being Scale - 9 items.
This scale comes from the Neurological Quality of Life Measurement System (Neuro QOL).
Raw scores were converted using the HealthMeasures scoring service to standardized T-Scores with M=50, SD=10 and ranging from 20 to 80. Higher scores indicate greater positive affect and well-being, a better outcome.
|
Baseline and 4 weeks (pre to post-intervention)
|
|
Pain Catastrophizing Scale Scores
Time Frame: Baseline and 4 weeks (pre to post-intervention)
|
Pain Catastrophizing Scale.
Scores range from 0-52, with higher scores indicating more pain catastrophizing, or worse outcome.
|
Baseline and 4 weeks (pre to post-intervention)
|
|
Chronic Pain Acceptance Scores
Time Frame: Baseline and 4 weeks (pre to post-intervention)
|
Chronic Pain Acceptance Questionnaire-Revised.
Scores range from 0-120 with higher scores representing higher chronic pain acceptance, a better outcome.
|
Baseline and 4 weeks (pre to post-intervention)
|
|
Trait Mindfulness Scores
Time Frame: Baseline and 4 weeks (pre to post-intervention)
|
Freiburg Mindfulness Inventory.
Possible scores range from 14 to 52, with higher scores indicating greater mindfulness, a better outcome.
|
Baseline and 4 weeks (pre to post-intervention)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Carrie Brintz, PhD, University of North Carolina, Chapel Hill
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
April 23, 2018
Primary Completion (ACTUAL)
October 26, 2018
Study Completion (ACTUAL)
October 26, 2018
Study Registration Dates
First Submitted
March 21, 2018
First Submitted That Met QC Criteria
April 10, 2018
First Posted (ACTUAL)
April 12, 2018
Study Record Updates
Last Update Posted (ACTUAL)
September 9, 2019
Last Update Submitted That Met QC Criteria
July 30, 2019
Last Verified
March 1, 2019
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 17-2948
- 2KR941702 (OTHER_GRANT: North Carolina Translational and Clinical Sciences Institute)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.